SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-11-023629
Filing Date
2011-04-28
Accepted
2011-04-28 14:35:42
Documents
10
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 PDL BIOPHARMA INC 10-Q 3-31-2011 form10q.htm 10-Q 896932
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9934
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 10015
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 6685
5 LOGO 1 logo1.jpg GRAPHIC 4794
  Complete submission text file 0001140361-11-023629.txt   3178226

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pdli-20110331.xml EX-101.INS 441643
7 XBRL TAXONOMY EXTENSION SCHEMA pdli-20110331.xsd EX-101.SCH 13862
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pdli-20110331_cal.xml EX-101.CAL 40797
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdli-20110331_lab.xml EX-101.LAB 163779
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdli-20110331_pre.xml EX-101.PRE 88721
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 11787498
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1